Appreciate your response tin tin, but still a little confused.
Given that two patients withdrew shouldn't there still be 12 lines on the graph? If I understand you correctly, you're suggesting the reason there is only 7 lines is that the other 5 patients either died or became too sick to assess. I still thought their antibody levels would have been relevant (ie reportable), unless they became too sick to assess between dosing and the first assessment period (which I guess is possible).
"I would assume the patient on the trial who is still with us 18months later, "whose tumour burden has been reduced to zero" would be the patient in the 10μg cohort who had a complete response. I would like to see what their antibody levels were like at such a low dose."
Isn't this the yellow line running on the x-axis? It looks like the longest-surviving patient had no immune response to IMU-201. What am I missing?
- Forums
- ASX - By Stock
- IMU
- Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC
Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC, page-58
-
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
0.001(0.96%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.2¢ | 5.4¢ | 5.2¢ | $177.0K | 3.350M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 2266655 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 335742 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 2164255 | 0.052 |
40 | 3985487 | 0.051 |
71 | 5878895 | 0.050 |
18 | 2391726 | 0.049 |
21 | 798435 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 331558 | 13 |
0.054 | 2138602 | 16 |
0.055 | 3657119 | 14 |
0.056 | 2701070 | 13 |
0.057 | 446030 | 6 |
Last trade - 11.51am 26/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online